Keshari et al., 2005 - Google Patents
Characterization of intervertebral disc degeneration by high‐resolution magic angle spinning (HR‐MAS) spectroscopyKeshari et al., 2005
- Document ID
- 7683774177449097815
- Author
- Keshari K
- Zektzer A
- Swanson M
- Majumdar S
- Lotz J
- Kurhanewicz J
- Publication year
- Publication venue
- Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine
External Links
Snippet
The goal of this study was to determine the ability of high‐resolution magic angle spinning (HR‐MAS) NMR spectroscopy to distinguish different stages of intervertebral disc degeneration (IVDD). 17 discs were removed from human cadavers and analyzed them …
- 238000004008 high resolution magic-angle spinning 0 title abstract description 35
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/4625—Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/385—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field using gradient magnetic field coils
- G01R33/3854—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field using gradient magnetic field coils means for active and/or passive vibration damping or acoustical noise suppression in gradient magnet coil systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/3806—Open magnet assemblies for improved access to the sample, e.g. C-type or U-type magnets
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/60—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using electron paramagnetic resonance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Keshari et al. | Characterization of intervertebral disc degeneration by high‐resolution magic angle spinning (HR‐MAS) spectroscopy | |
US20220142498A1 (en) | Systems and methods using nuclear magnetic resonance (nmr) spectroscopy to evaluate pain and degenerative properties of tissue | |
Johannessen et al. | Assessment of human disc degeneration and proteoglycan content using T1ρ-weighted magnetic resonance imaging | |
Reiter et al. | Multicomponent T2 relaxation analysis in cartilage | |
Horch et al. | Origins of the ultrashort‐T2 1H NMR signals in myelinated nerve: a direct measure of myelin content? | |
Glaser | New techniques for cartilage imaging: T2 relaxation time and diffusion-weighted MR imaging | |
Trattnig et al. | Advanced MR methods at ultra-high field (7 Tesla) for clinical musculoskeletal applications | |
Zbýň et al. | Evaluation of cartilage repair and osteoarthritis with sodium MRI | |
AU2012244378B2 (en) | Systems and methods using nuclear magnetic resonance (NMR) spectroscopy to evaluate pain and degenerative properties of tissue | |
Yoon et al. | T1rho and T2 mapping of lumbar intervertebral disc: correlation with degeneration and morphologic changes in different disc regions | |
Trattnig et al. | Magnetic resonance imaging of cartilage repair: a review | |
Welsch et al. | Magnetization transfer contrast and T2 mapping in the evaluation of cartilage repair tissue with 3T MRI | |
Navon et al. | Study of order and dynamic processes in tendon by NMR and MRI | |
Schlaeger et al. | Decreased water T2 in fatty infiltrated skeletal muscles of patients with neuromuscular diseases | |
Majumdar et al. | Diagnostic tools and imaging methods in intervertebral disk degeneration | |
Wang et al. | Advances in magnetic resonance imaging for the assessment of degenerative disc disease of the lumbar spine | |
Majumdar | Magnetic resonance imaging and spectroscopy of the intervertebral disc | |
Min et al. | Evaluation of glycosaminoglycan in the lumbar disc using chemical exchange saturation transfer MR at 3.0 Tesla: reproducibility and correlation with disc degeneration | |
Regatte et al. | Depth‐dependent proton magnetization transfer in articular cartilage | |
Pykett et al. | Techniques and approaches to proton NMR imaging of the head | |
Wang et al. | Multiparametric MR investigation of proteoglycan diffusivity, T2 relaxation, and concentration in an ex vivo model of intervertebral disc degeneration | |
Berg et al. | High-resolution diffusivity imaging at 3.0 T for the detection of degenerative changes: a trypsin-based arthritis model | |
Regatte et al. | Novel contrast mechanisms at 3 Tesla and 7 Tesla | |
Kirov et al. | Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis | |
Athertya et al. | High contrast cartilaginous endplate imaging in spine using three dimensional dual-inversion recovery prepared ultrashort echo time (3D DIR-UTE) sequence |